Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Quadruple Therapy for H. Pylori Eradication
NCT01335334Phase 4Unknown
- Sponsor
- UTHealth Houston
- Start
- Mar 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in Helicobacter pylori infection, sponsored by UTHealth Houston. Status: unknown.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01335334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335334.